{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T20:42:03Z","timestamp":1780692123435,"version":"3.54.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":3446,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1038\/sj.ki.5001594","type":"journal-article","created":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T04:08:43Z","timestamp":1151640523000},"page":"S3-S7","source":"Crossref","is-referenced-by-count":48,"special_numbering":"S102","title":["Basic and clinical aspects of parathyroid hyperplasia in chronic kidney disease"],"prefix":"10.1016","volume":"70","author":[{"given":"M.","family":"Fukagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Kazama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1038\/sj.ki.5001594_bb0010","first-page":"S63","article-title":"Uremic bone diseases: advances over the last 30 years","volume":"12","author":"Kurokawa","year":"1999","journal-title":"J Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0015","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Drueke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0020","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1744-9987.2005.00328.x","article-title":"An overview of regular dialysis treatment in Japan as of 31 December 2003","volume":"9","author":"Patient Registration Committee, Japanese Society for Dialysis Therapy","year":"2005","journal-title":"Ther Apher Dial"},{"key":"10.1038\/sj.ki.5001594_bb0025","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1046\/j.1523-1755.1999.00396.x","article-title":"Expression of PRAD1\/cyclin D1, retinoblastoma gene products, and Ki67 in parathyroid hyperplasia caused by chronic renal failure versus primary adenoma","volume":"55","author":"Tominaga","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0030","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1097\/01.ASN.0000018148.50109.C0","article-title":"Clonal chromosomal defects in the molecular pathogenesis of refractory hyperparathyroidism of uremia","volume":"13","author":"Imanishi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0035","first-page":"139","article-title":"Progression of uremic hyperparathyroidism involves allelic loss on chromosome 11","volume":"76","author":"Falcetti","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001594_bb0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/(SICI)1098-2388(199703\/04)13:2<78::AID-SSU3>3.0.CO;2-Z","article-title":"Histopathology, pathophysiology, and indications for surgical treatment of renal hyperparathyroidism","volume":"13","author":"Tominaga","year":"1997","journal-title":"Semin Surg Oncol"},{"key":"10.1038\/sj.ki.5001594_bb0045","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/BF01655411","article-title":"Secretory disturbance in hyperplastic parathyroid nodules of uremic hyperparathyroidism: implication for parathyroid autotransplantation","volume":"12","author":"Wallfelt","year":"1988","journal-title":"World J Surg"},{"key":"10.1038\/sj.ki.5001594_bb0050","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI114022","article-title":"Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium","volume":"83","author":"Delmez","year":"1989","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001594_bb0055","doi-asserted-by":"crossref","first-page":"F367","DOI":"10.1152\/ajprenal.00061.2002","article-title":"Mechanisms of secondary hyperparathyroidism","volume":"283","author":"Silver","year":"2002","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5001594_bb0060","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001594_bb0065","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s002689900113","article-title":"Clonal analysis of nodular parathyroid hyperplasia in renal hyperparathyroidism","volume":"20","author":"Tominaga","year":"1996","journal-title":"World J Surg"},{"key":"10.1038\/sj.ki.5001594_bb0070","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1172\/JCI116720","article-title":"Decreased 1,25-dihydroxyvitamin D3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients","volume":"92","author":"Fukuda","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001594_bb0075","first-page":"1598","article-title":"Reduced immunostaining for the extracellular Ca2+-sensing receptor in primary and uremic secondary hyperparathyroidism","volume":"81","author":"Kifor","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001594_bb0080","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1111\/j.1523-1755.2002.kid585.x","article-title":"Reduced p21, p27 and vitamin D receptor in the nodular hyperplasia in patients with advanced secondary hyperparathyroidism","volume":"62","author":"Tokumoto","year":"2002","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0085","doi-asserted-by":"crossref","first-page":"F1096","DOI":"10.1152\/ajprenal.00167.2005","article-title":"A critical role for enhanced TGF-alpha and EGFR expression in the initiation of parathyroid hyperplasia in experimental kidney disease","volume":"289","author":"Cozzolino","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/sj.ki.5001594_bb0090","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1111\/j.1523-1755.2005.00330.x","article-title":"Progression of secondary hyperparathyroidism involves degradation of genes related to DNA and RNA stability","volume":"67","author":"Santamaria","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/jc.2005-2155","article-title":"Upregulation of the gene encoding protein kinase A type I\u03b1 regulatory subunit in nodular hyperplasia of parathyroid glands in patients with chronic renal failure","volume":"91","author":"Hibi","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001594_bb0100","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/S0272-6386(03)00905-3","article-title":"K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","author":"National Kidney Foundation","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001594_bb0105","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/ndt\/17.9.1553","article-title":"Management of the patients with advanced secondary hyperparathyroidism: the Japanese approach","volume":"17","author":"Fukagawa","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001594_bb0110","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0272-6386(00)70199-5","article-title":"Presence of sonographically detectable parathyroid glands can predict resistance to oral pulse-dose calcitriol treatment of secondary hyperparathyroidism","volume":"35","author":"Katoh","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001594_bb0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000188261","article-title":"Serial evaluation of parathyroid size by ultrasonography is another useful marker for the long-term prognosis of calcitriol pulse therapy in chronic dialysis patient","volume":"68","author":"Fukagawa","year":"1994","journal-title":"Nephron"},{"key":"10.1038\/sj.ki.5001594_bb0120","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1093\/ndt\/gfg451","article-title":"Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism","volume":"18","author":"Okuno","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5001594_bb0125","first-page":"iii34","article-title":"Evaluation of blood supply to parathyroid glands in secondary hyperparathyroidism compared with histopathology","volume":"18","author":"Onoda","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001594_bb0130","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1373\/clinchem.2003.021592","article-title":"Amino-terminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH(1\u201384) is overproduced in primary and secondary hyperparathyroidism","volume":"49","author":"D\u2019Amour","year":"2003","journal-title":"Clin Chem"},{"key":"10.1038\/sj.ki.5001594_bb0135","doi-asserted-by":"crossref","first-page":"69","DOI":"10.5414\/CNP64069","article-title":"Normalization of reversed bio-intact-PTH(1\u201384)\/intact-PTH ratio after parathyroidectomy in a patient with severe secondary hyperparathyroidism","volume":"64","author":"Tanaka","year":"2005","journal-title":"Clin Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0140","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/sj.ki.5001594_bb0145","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.semnephrol.2003.08.016","article-title":"Renal phosphate wasting disorders: clinical features and pathogenesis","volume":"24","author":"Brame","year":"2004","journal-title":"Semin Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of the vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1038\/sj.ki.5001594_bb0155","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ndt\/gfh827","article-title":"With or without the kidney: the role of FGF23 in CKD","volume":"20","author":"Fukagawa","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001594_bb0160","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"FGF-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001594_bb0165","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5001594_bb0170","series-title":"Kidney Int","article-title":"Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats","author":"Nagano","year":"2006"},{"key":"10.1038\/sj.ki.5001594_bb0175","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1053\/j.ajkd.2004.04.029","article-title":"Possible involvement of circulating fibroblast growth factor-23 in the development of secondary hyperparathyroidism associated with renal insufficiency","volume":"44","author":"Shigematsu","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001594_bb0180","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0185","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1172\/JCI118701","article-title":"Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro","volume":"97","author":"Slatopolsky","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1038\/sj.ki.5001594_bb0190","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1523-1755.2004.00604.x","article-title":"FGF-23 in patients with end-stage renal disease on hemodialysis","volume":"65","author":"Imanishi","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0195","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00184.x","article-title":"Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients","volume":"67","author":"Nakanishi","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0200","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/j.1523-1755.2005.00178.x","article-title":"Pretreatment serum FGF-23 levels predict the efficacy of calcitriol therapy in dialysis patients","volume":"67","author":"Kazama","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0205","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha (I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1038\/sj.ki.5001594_bb0210","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001594_bb0215","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1530\/eje.0.1510055","article-title":"Fibroblast growth factor (FGF)-23 in patients with primary hyperparathyroidism","volume":"151","author":"Yamashita","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1038\/sj.ki.5001594_bb0220","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"10.1038\/sj.ki.5001594_bb0225","doi-asserted-by":"crossref","first-page":"c94","DOI":"10.1159\/000086347","article-title":"Intravenous calcitriol therapy increases serum concentrations of fibroblast growth factor-23 in dialysis patients with secondary hyperparathyroidism","volume":"101","author":"Nishi","year":"2005","journal-title":"Nephron Clin Pract"},{"key":"10.1038\/sj.ki.5001594_bb0230","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1038\/sj.ki.5001594_bb0235","doi-asserted-by":"crossref","first-page":"E1101","DOI":"10.1152\/ajpendo.00502.2004","article-title":"Vitamin D and phosphate regulate fibroblast growth factor-23 in K562 cells","volume":"288","author":"Ito","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1038\/sj.ki.5001594_bb0240","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1359\/JBMR.050718","article-title":"Fibroblast growth factor-23 is regulated by 1 alpha, 25-dihydroxyvitamin D","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1038\/sj.ki.5001594_bb0245","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1 alpha, 25-hydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal\u2013gastrointestinal\u2013skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1038\/sj.ki.5001594_bb0250","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine action of fibroblast growth factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"},{"issue":"Suppl 73","key":"10.1038\/sj.ki.5001594_bb0255","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1046\/j.1523-1755.1999.07309.x","article-title":"Medical and surgical aspects of parathyroidectomy","volume":"56","author":"Fukagawa","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0260","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ki.1994.373","article-title":"Reduction of functioning parathyroid cell mass by ethanol injection in chronic dialysis patients","volume":"46","author":"Kitaoka","year":"1994","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0265","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0272-6386(99)70146-0","article-title":"Prognosis of parathyroid function after successful percutaneous ethanol injection therapy (PEIT) guided by color Doppler flow mapping in chronic dialysis patients","volume":"33","author":"Kakuta","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5001594_bb0270","first-page":"iii31","article-title":"Guideline for percutaneous ethanol injection therapy of the parathyroid glands in chronic dialysis patients","volume":"18","author":"Fukagawa","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001594_bb0275","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM199008093230617","article-title":"Regression of parathyroid hyperplasia by calcitriol-pulse therapy in patients on long-term dialysis","volume":"323","author":"Fukagawa","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1038\/sj.ki.5001594_bb0280","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0272-6386(04)00956-4","article-title":"Infarction of mediastinal parathyroid gland causing spontaneous remission of secondary hyperparathyroidism","volume":"44","author":"Tanaka","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1038\/sj.ki.5001594_bb0285","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1093\/ndt\/gfi337","article-title":"Autoinfarction of the parathyroid gland diagnosed by power Doppler ultrasonography in a patient with secondary hyperparathyroidism","volume":"21","author":"Tanaka","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001594_bb0290","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1111\/j.1440-1797.1995.tb00056.x","article-title":"Direct injections of calciriol into parathyroid hyperplasia in chronic dialysis patients with severe parathyroid hyperfunction","volume":"1","author":"Kitaoka","year":"1995","journal-title":"Nephrology"},{"issue":"Suppl 3","key":"10.1038\/sj.ki.5001594_bb0295","first-page":"iii38","article-title":"Percutaneous calcitriol injection therapy (PCIT) for secondary hyperparathyroidism: multicenter trial","volume":"18","author":"Kitaoka","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/sj.ki.5001594_bb0300","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1046\/j.1523-1755.2003.00154.x","article-title":"Percutaneous maxacalcitol injection therapy regresses hyperplasia of parathyroid and induces apoptosis in uremia","volume":"64","author":"Shiizaki","year":"2003","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0305","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1046\/j.1523-1755.2000.00863.x","article-title":"Apoptosis in parathyroid hyperplasia of patients with primary or secondary uremic hyperparathyroidism","volume":"57","author":"Zhang","year":"2000","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0310","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1681\/ASN.2004030236","article-title":"Biochemical and cellular effect of direct maxacalcitol injection into parathyroid gland in uremic rat","volume":"16","author":"Shiizaki","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/sj.ki.5001594_bb0315","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/sj.ki.5000090","article-title":"Parathyroid growth and regression in experimental uremia","volume":"69","author":"Taniguchi","year":"2006","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0320","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1254\/jphs.FMJ04007X6","article-title":"Functional proteins involved in regulation of intracellular Ca2+ for drug development: the extracellular calcium receptor and an innovative medical approach to control secondary hyperparathyroidism by calcimimetics","volume":"97","author":"Nagano","year":"2005","journal-title":"J Pharmacol Sci"},{"key":"10.1038\/sj.ki.5001594_bb0325","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","article-title":"Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism","volume":"67","author":"Colloton","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/sj.ki.5001594_bb0330","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1093\/ndt\/gfh924","article-title":"The calcimimetics cinacalcet normalizes serum calcium in renal transplant patients with persistent hyperparathyroidism","volume":"20","author":"Kruse","year":"2005","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815518176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815518176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T00:48:23Z","timestamp":1627519703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815518176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":65,"alternative-id":["S0085253815518176"],"URL":"https:\/\/doi.org\/10.1038\/sj.ki.5001594","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]}}}